Ricky Ghoshal joins Glysantis as Sr. Business Development Associate

Mirexus is pleased to announce that Ricky Ghoshal has joined Glysantis as Sr. Business Development Associate. Ricky recently completed an 8-month internship with Glysantis as part of McMaster University’s Master of Biomedical Discovery and Commercialization program. “Over the past 8-months Ricky has made considerable contributions to Glysantis. We are thrilled to have him join us full-time now that his program at McMaster is complete”, says Alison Crumblehulme, VP of Business Development. Ricky will support Glysantis’ commercialization efforts by conducting market research, identifying new...

read more

Alison Crumblehulme Promoted to Vice President Business Development

The Board of Directors of Mirexus are pleased to announce the promotion of Alison Crumblehulme to Vice President Business Development.  Alison started her career in R&D and then moved into business development while doing an MBA at Queen’s – before joining Mirexus ~2 years ago to lead our Business Development efforts. “Alison has quickly become a key member of the business leadership team at Mirexus, and we felt this change in title better reflects the importance of her role and contribution to the company”, says Dr. Phil Whiting, President & CEO of Mirexus.  “We are all...

read more

Mirexus’ Founder Dr. John Dutcher Receives University of Guelph Innovations of the Year Award.

Mirexus’ founder and physics professor Dr. John Dutcher received the University of Guelph Innovations of the Year Award for his work with nanoparticles. Mirexus’ platform material PhytoSpherix™,  ,which is a natural biopolymer extracted in the form of completely uniform-sized nanoparticles was discovered by Dutcher’s team at the University of Guelph. Read more (press release from UoG).

read more

Mirexus Biotechnologies Inc. raises $12 million to finance factory, fund business development, and deepen R&D

Guelph, ON – June 29, 2017 Mirexus Biotechnologies Inc. (Mirexus) is excited to announce that it has closed an investment round of $12 million.  Mirexus is a safe and natural nanomaterials company based in Guelph, Ontario that is commercializing PhytoSpherix™, a novel technology based on polysaccharide nanoparticles that can be used in a wide variety of markets ranging from cosmetics to nutraceuticals to applications in human health.  The funds will be used to finance a factory to produce PhytoSpherix™, and to fund at least three years of operations as the company grows. GEL Tech (Canada),...

read more

Dr. Karl Klinger receives Talent Edge postdoctoral research award from the Ontario Centres of Excellence

Mirexus is pleased to announce that Dr. Karl Klinger has recently received an OCE Talent Edge postdoctoral research award. The OCE (Ontario Centres of Excellence) Talent Edge award provides 1 year of research funding in industry for top recent PhD graduates. Karl has a PhD in chemistry from University of Natural Resources and Life Sciences, Vienna.  At Mirexus, his focus is on modifying the surface chemistry of Phytospherix™ (a natural carbohydrate) for biomedical applications.

read more